AKAP12 and prostate carcinoma: AKAP12 (also known as SSeCKS, Gravin or AKAP250) functions as a metastasis suppressor in prostate cancer models [7–9] based on its ability to scaffold kinases such as Src, PKC and PKA, and to suppress their activation of downstream signaling mediators [10].